Neuberger Berman Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $196M | Sell |
862,704
-11,674
| -1% | -$2.08M | 0.13% | 171 |
|
|
2026
Q1 | $151M | Buy |
874,378
+14,220
| +2% | +$2.64M | 0.11% | 212 |
|
|
2025
Q4 | $172M | Buy |
860,158
+10,646
| +1% | +$1.93M | 0.13% | 181 |
|
|
2025
Q3 | $133M | Buy |
849,512
+154,798
| +22% | +$24.6M | 0.1% | 261 |
|
|
2025
Q2 | $105M | Buy |
694,714
+103,732
| +18% | +$13.8M | 0.08% | 297 |
|
|
2025
Q1 | $89.1M | Buy |
590,982
+281,793
| +91% | +$47.2M | 0.07% | 324 |
|
|
2024
Q4 | $57.1M | Sell |
309,189
-3,773
| -1% | -$727K | 0.05% | 407 |
|
|
2024
Q3 | $61.7M | Buy |
312,962
+5,505
| +2% | +$1.14M | 0.05% | 405 |
|
|
2024
Q2 | $63.5M | Buy |
307,457
+40,634
| +15% | +$9.21M | 0.05% | 370 |
|
|
2024
Q1 | $72.3M | Sell |
266,823
-248,445
| -48% | -$59.3M | 0.06% | 346 |
|
|
2023
Q4 | $122M | Buy |
515,268
+253,908
| +97% | +$49.9M | 0.05% | 370 |
|
|
2023
Q3 | $51.2M | Sell |
261,360
-1,299
| -0.5% | -$267K | 0.05% | 407 |
|
|
2023
Q2 | $55.2M | Buy |
262,659
+2,138
| +0.8% | +$425K | 0.05% | 394 |
|
|
2023
Q1 | $52.5M | Buy |
260,521
+3,713
| +1% | +$841K | 0.05% | 409 |
|
|
2022
Q4 | $56M | Sell |
256,808
-706
| -0.3% | -$154K | 0.05% | 388 |
|
|
2022
Q3 | $50.6M | Buy |
257,514
+7,565
| +3% | +$1.63M | 0.05% | 416 |
|
|
2022
Q2 | $53.5M | Buy |
249,949
+4,057
| +2% | +$991K | 0.05% | 396 |
|
|
2022
Q1 | $69.9M | Sell |
245,892
-20,877
| -8% | -$6.44M | 0.06% | 394 |
|
|
2021
Q4 | $98.8M | Buy |
266,769
+1,212
| +0.5% | +$471K | 0.08% | 331 |
|
|
2021
Q3 | $108M | Sell |
265,557
-103,669
| -28% | -$43.1M | 0.09% | 296 |
|
|
2021
Q2 | $135M | Sell |
369,226
-46,454
| -11% | -$15.5M | 0.12% | 260 |
|
|
2021
Q1 | $120M | Sell |
415,680
-122,800
| -23% | -$34.1M | 0.11% | 260 |
|
|
2020
Q4 | $134M | Sell |
538,480
-9,342
| -2% | -$2.22M | 0.14% | 214 |
|
|
2020
Q3 | $124M | Sell |
547,822
-142,824
| -21% | -$29.6M | 0.15% | 197 |
|
|
2020
Q2 | $120M | Sell |
690,646
-24,673
| -3% | -$3.94M | 0.15% | 184 |
|
|
2020
Q1 | $90.3M | Buy |
715,319
+66,938
| +10% | +$10M | 0.14% | 201 |
|
|
2019
Q4 | $99M | Buy |
648,381
+59,863
| +10% | +$8.29M | 0.12% | 250 |
|
|
2019
Q3 | $77.9M | Buy |
588,518
+26,295
| +5% | +$3.53M | 0.1% | 294 |
|
|
2019
Q2 | $79.8M | Sell |
562,223
-9,203
| -2% | -$1.25M | 0.1% | 300 |
|
|
2019
Q1 | $83M | Sell |
571,426
-17,066
| -3% | -$2.24M | 0.1% | 284 |
|
|
2018
Q4 | $66.6M | Sell |
588,492
-9,133
| -2% | -$1.14M | 0.09% | 303 |
|
|
2018
Q3 | $80.4M | Sell |
597,625
-60,372
| -9% | -$7.45M | 0.09% | 313 |
|
|
2018
Q2 | $73.9M | Sell |
657,997
-24,232
| -4% | -$2.62M | 0.08% | 326 |
|
|
2018
Q1 | $72.8M | Sell |
682,229
-37,590
| -5% | -$4.05M | 0.08% | 317 |
|
|
2017
Q4 | $78.8M | Sell |
719,819
-65,405
| -8% | -$7.12M | 0.09% | 312 |
|
|
2017
Q3 | $84.8M | Sell |
785,224
-42,506
| -5% | -$4.37M | 0.11% | 285 |
|
|
2017
Q2 | $83.7M | Sell |
827,730
-48,903
| -6% | -$4.5M | 0.11% | 281 |
|
|
2017
Q1 | $78.9M | Buy |
876,633
+6,148
| +0.7% | +$522K | 0.1% | 298 |
|
|
2016
Q4 | $66.3M | Buy |
870,485
+7,105
| +0.8% | +$540K | 0.09% | 321 |
|
|
2016
Q3 | $72M | Sell |
863,380
-14,533
| -2% | -$1.22M | 0.1% | 298 |
|
|
2016
Q2 | $72.4M | Buy |
877,913
+5,966
| +0.7% | +$491K | 0.1% | 279 |
|
|
2016
Q1 | $66.2M | Buy |
871,947
+81,354
| +10% | +$6.02M | 0.09% | 303 |
|
|
2015
Q4 | $63.6M | Buy |
790,593
+4,275
| +0.5% | +$308K | 0.08% | 326 |
|
|
2015
Q3 | $49.9M | Buy |
786,318
+35,019
| +5% | +$2.51M | 0.06% | 367 |
|
|
2015
Q2 | $52.8M | Sell |
751,299
-12,804
| -2% | -$948K | 0.06% | 405 |
|
|
2015
Q1 | $60.6M | Sell |
764,103
-6,499
| -0.8% | -$479K | 0.06% | 381 |
|
|
2014
Q4 | $49M | Sell |
770,602
-1,622
| -0.2% | -$102K | 0.05% | 428 |
|
|
2014
Q3 | $46.1M | Buy |
772,224
+927
| +0.1% | +$53K | 0.05% | 449 |
|
|
2014
Q2 | $41.3M | Sell |
771,297
-12,415
| -2% | -$681K | 0.04% | 474 |
|
|
2014
Q1 | $47.3M | Sell |
783,712
-109,387
| -12% | -$6.38M | 0.05% | 433 |
|
|
2013
Q4 | $47.4M | Sell |
893,099
-10,495
| -1% | -$527K | 0.05% | 436 |
|
|
2013
Q3 | $41.8M | Buy |
903,594
+27,007
| +3% | +$1.24M | 0.05% | 444 |
|
|
2013
Q2 | $36M | Buy |
+876,587
| New | +$37.6M | 0.04% | 470 |
|
Other funds holding CRL
AI
Neuberger Berman Group's CRL Position: Q2 2026 in Review
Neuberger Berman Group reduced its Charles River Laboratories (CRL) stake by 1.3% in Q2 2026, selling an estimated $2.08M and leaving 862,704 shares worth $196M. The position accounts for 0.13% of the portfolio, ranked #171.
Neuberger Berman Group first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Neuberger Berman Group held 862,704 shares of Charles River Laboratories worth $196M as of Q2 2026.
- Neuberger Berman Group sold 11,674 Charles River Laboratories shares in Q2 2026, an estimated $2.08M.
- Charles River Laboratories made up 0.13% of Neuberger Berman Group's portfolio in Q2 2026, its #171 holding.
- Neuberger Berman Group first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
- 568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.